These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 22439282

  • 1. Development of a mouse food pad model for detection of sub clinical leprosy.
    Lahiri R, Randhawa B, Franken KL, Duthie MS, Spencer JS, Geluk A, Krahenbuhl JL.
    Lepr Rev; 2011 Dec; 82(4):432-44. PubMed ID: 22439282
    [Abstract] [Full Text] [Related]

  • 2. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
    Geluk A, van der Ploeg J, Teles RO, Franken KL, Prins C, Drijfhout JW, Sarno EN, Sampaio EP, Ottenhoff TH.
    Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740
    [Abstract] [Full Text] [Related]

  • 3. Cytokine responses to Mycobacterium leprae unique proteins differentiate between Mycobacterium leprae infected and naive armadillos.
    Pena M, Geluk A, Van Der Ploeg-Van Schip JJ, Franken KL, Sharma R, Truman R.
    Lepr Rev; 2011 Dec; 82(4):422-31. PubMed ID: 22439281
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa.
    Bobosha K, Van Der Ploeg-Van Schip JJ, Zewdie M, Sapkota BR, Hagge DA, Franken KL, Inbiale W, Aseffa A, Ottenhoff TH, Geluk A.
    Lepr Rev; 2011 Dec; 82(4):445-58. PubMed ID: 22439283
    [Abstract] [Full Text] [Related]

  • 5. HLA and leprosy in the pre and postgenomic eras.
    Geluk A, Ottenhoff TH.
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [Abstract] [Full Text] [Related]

  • 6. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
    Levy L, Ji B.
    Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
    [Abstract] [Full Text] [Related]

  • 7. Postgenomic Mycobacterium leprae antigens for cellular and serological diagnosis of M. leprae exposure, infection and leprosy disease.
    Geluk A, Duthie MS, Spencer JS.
    Lepr Rev; 2011 Dec; 82(4):402-21. PubMed ID: 22439280
    [Abstract] [Full Text] [Related]

  • 8. Genetic control of murine T cell proliferative responses to Mycobacterium leprae. V. Evidence for cross-reactivity between host antigens and Mycobacterium leprae.
    Harris DP, Jones AG, Wade S, Krahenbuhl JL, Gillis TP, Watson JD.
    J Immunol; 1988 Sep 01; 141(5):1695-700. PubMed ID: 2970509
    [Abstract] [Full Text] [Related]

  • 9. Susceptibility to Mycobacterium leprae of ALY (alymphoplasia) mice and IFN-gamma induction in the culture supernatant of spleen cells.
    Yogi Y, Endoh M, Banba T, Okamura H, Nomaguchi H.
    Int J Lepr Other Mycobact Dis; 1998 Dec 01; 66(4):464-74. PubMed ID: 10347567
    [Abstract] [Full Text] [Related]

  • 10. The study of Mycobacterium leprae infection in interferon-gamma gene--disrupted mice as a model to explore the immunopathologic spectrum of leprosy.
    Adams LB, Scollard DM, Ray NA, Cooper AM, Frank AA, Orme IM, Krahenbuhl JL.
    J Infect Dis; 2002 Feb 15; 185 Suppl 1():S1-8. PubMed ID: 11865434
    [Abstract] [Full Text] [Related]

  • 11. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR, Janson AM, Thole JE, Buhrer S, Bos C, Soebono H, de Vries RR.
    Int J Lepr Other Mycobact Dis; 1997 Jun 15; 65(2):178-89. PubMed ID: 9251589
    [Abstract] [Full Text] [Related]

  • 12. Cytokine gene expression in the foot pad and spleen of BALB/cAJcl mice infected with M. leprae.
    Yogi Y, Nomaguchi H, Sakamoto Y, Matsuoka M, Fujimura T, Okamura H, Hioki K, Saito M, Nomura T.
    Int J Lepr Other Mycobact Dis; 1997 Mar 15; 65(1):80-9. PubMed ID: 9207757
    [Abstract] [Full Text] [Related]

  • 13. Biomarkers for leprosy: would you prefer T (cells)?
    Geluk A.
    Lepr Rev; 2013 Mar 15; 84(1):3-12. PubMed ID: 23741878
    [Abstract] [Full Text] [Related]

  • 14. Reconstitution of Mycobacterium leprae immunity in severe combined immunodeficient mice using a T-cell line.
    Azouaou N, Gelber RH, Abel K, Sasaki DT, Murray LP, Locksley RM, Mohagheghpour N.
    Int J Lepr Other Mycobact Dis; 1993 Sep 15; 61(3):398-405. PubMed ID: 8228438
    [Abstract] [Full Text] [Related]

  • 15. Immunity to leprosy. 1. The proliferative response of murine T lymphocytes to Mycobacterium leprae.
    Douglas-Jones AG, Watson JD.
    Int J Lepr Other Mycobact Dis; 1985 Sep 15; 53(3):412-20. PubMed ID: 3900249
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH, Converse PJ, Gebre N, Wondimu A, Ehrenberg JP, Kiessling R.
    Eur J Immunol; 1989 Apr 15; 19(4):707-13. PubMed ID: 2659369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.